News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
698,147 Results
Type
Article (39664)
Company Profile (247)
Press Release (658236)
Multimedia
Podcasts (49)
Webinars (12)
Section
Business (204152)
Career Advice (2007)
Deals (35414)
Drug Delivery (95)
Drug Development (81042)
Employer Resources (172)
FDA (16177)
Job Trends (14854)
News (345162)
Policy (32531)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (1)
2024 BioForest Standard (1)
2024 BioMidwest Digital (7)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (4)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (17)
2024 Biotech Beach Digital (8)
2024 Biotech Beach Standard (4)
2024 Genetown Digital (5)
2024 Genetown Standard (8)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (5)
2024 Pharm Country Standard (4)
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (5)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Bio NC Standard (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Genetown Standard (1)
2026 Pharm Country Standard (2)
Academia (2555)
Accelerated approval (5)
Adcomms (20)
Allergies (83)
Alliances (49421)
ALS (88)
Alzheimer's disease (1374)
Antibody-drug conjugate (ADC) (124)
Approvals (16179)
Artificial intelligence (246)
Autoimmune disease (21)
Automation (16)
Bankruptcy (360)
Best Places to Work (11636)
BIOSECURE Act (19)
Biosimilars (105)
Biotechnology (175)
Bladder cancer (76)
Brain cancer (26)
Breast cancer (272)
Cancer (2203)
Cardiovascular disease (171)
Career advice (1675)
Career pathing (30)
CAR-T (145)
Cell therapy (409)
Cervical cancer (19)
Clinical research (65937)
Collaboration (819)
Compensation (522)
Complete response letters (19)
COVID-19 (2585)
CRISPR (37)
C-suite (232)
Cystic fibrosis (100)
Data (2126)
Decentralized trials (2)
Denatured (18)
Depression (41)
Diabetes (263)
Diagnostics (6360)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (120)
Drug pricing (98)
Drug shortages (25)
Duchenne muscular dystrophy (93)
Earnings (86451)
Editorial (35)
Employer branding (21)
Employer resources (146)
Events (112181)
Executive appointments (713)
FDA (17396)
Featured Employer (47)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (743)
Gene editing (100)
Generative AI (19)
Gene therapy (290)
GLP-1 (703)
Government (4411)
Grass and pollen (4)
Guidances (53)
Healthcare (18814)
Huntington's disease (23)
IgA nephropathy (25)
Immunology and inflammation (112)
Indications (28)
Infectious disease (2727)
Inflammatory bowel disease (135)
Inflation Reduction Act (8)
Influenza (51)
Intellectual property (93)
Interviews (311)
IPO (16499)
IRA (40)
Job creations (3630)
Job search strategy (1422)
Kidney cancer (10)
Labor market (38)
Layoffs (463)
Leadership (16)
Legal (7909)
Liver cancer (73)
Lung cancer (314)
Lymphoma (150)
Machine learning (6)
Management (58)
Manufacturing (296)
MASH (65)
Medical device (13365)
Medtech (13370)
Mergers & acquisitions (19444)
Metabolic disorders (669)
Multiple sclerosis (77)
NASH (16)
Neurodegenerative disease (84)
Neuropsychiatric disorders (27)
Neuroscience (1890)
NextGen: Class of 2025 (6512)
Non-profit (4478)
Northern California (2616)
Now hiring (39)
Obesity (358)
Opinion (204)
Ovarian cancer (73)
Pain (83)
Pancreatic cancer (81)
Parkinson's disease (146)
Partnered (21)
Patents (229)
Patient recruitment (105)
Peanut (46)
People (57260)
Pharmaceutical (63)
Pharmacy benefit managers (18)
Phase I (20536)
Phase II (29036)
Phase III (21634)
Pipeline (1143)
Policy (136)
Postmarket research (2563)
Preclinical (8712)
Press Release (64)
Prostate cancer (103)
Psychedelics (30)
Radiopharmaceuticals (245)
Rare diseases (374)
Real estate (5907)
Recruiting (65)
Regulatory (22244)
Reports (46)
Research institute (2319)
Resumes & cover letters (349)
Rett syndrome (4)
RNA editing (4)
RSV (42)
Schizophrenia (66)
Series A (129)
Series B (84)
Service/supplier (11)
Sickle cell disease (52)
Southern California (2252)
Special edition (14)
Spinal muscular atrophy (147)
Sponsored (29)
Startups (3575)
State (2)
Stomach cancer (13)
Supply chain (67)
Tariffs (33)
The Weekly (29)
United States (22583)
Vaccines (679)
Venture capitalists (41)
Weight loss (231)
Women's health (35)
Worklife (15)
Date
Today (187)
Last 7 days (742)
Last 30 days (2406)
Last 365 days (32857)
2025 (10029)
2024 (35219)
2023 (40076)
2022 (51173)
2021 (55710)
2020 (54083)
2019 (46541)
2018 (35020)
2017 (32114)
2016 (31481)
2015 (37553)
2014 (31319)
2013 (26345)
2012 (28570)
2011 (29264)
2010 (27328)
Location
Africa (718)
Alabama (52)
Alaska (7)
Arizona (230)
Arkansas (13)
Asia (37816)
Australia (6179)
California (5973)
Canada (1977)
China (511)
Colorado (261)
Connecticut (267)
Delaware (141)
Europe (81139)
Florida (881)
Georgia (203)
Idaho (57)
Illinois (523)
India (25)
Indiana (305)
Iowa (11)
Japan (157)
Kansas (102)
Kentucky (23)
Louisiana (10)
Maine (62)
Maryland (872)
Massachusetts (4461)
Michigan (216)
Minnesota (385)
Mississippi (2)
Missouri (81)
Montana (27)
Nebraska (25)
Nevada (63)
New Hampshire (62)
New Jersey (1687)
New Mexico (28)
New York (1698)
North Carolina (951)
North Dakota (7)
Northern California (2616)
Ohio (199)
Oklahoma (14)
Oregon (34)
Pennsylvania (1338)
Puerto Rico (11)
Rhode Island (32)
South America (1096)
South Carolina (22)
South Dakota (1)
Southern California (2252)
Tennessee (101)
Texas (883)
Utah (177)
Virginia (142)
Washington D.C. (61)
Washington State (544)
West Virginia (3)
Wisconsin (52)
698,147 Results for "embera neurotherapeutics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Stream Biomedical, Inc. Announces Acceptance of Abstract for Presentation at Annual Meeting of the American Society of Neurotherapeutics (ASENT) Conference 2025
March 5, 2025
·
2 min read
Drug Development
Our Mission at Voyager Therapeutics: Define the Future of Neurogenetic Medicines
We are in an unprecedented time in neurotherapeutics. Medicines that address the causative disease biology underlying central nervous system
May 8, 2024
·
2 min read
·
Voyager Therapeutics, Inc.
Drug Development
Embera NeuroTherapeutics Announces First Subject Dosed in Phase 2a Study of EMB-001 in Smoking Cessation
Embera NeuroTherapeutics Announces First Subject Dosed in Phase 2a Study of EMB-001 in Smoking Cessation
June 30, 2021
·
5 min read
Avenue Therapeutics to Present BAER-101 Preclinical Data at American Society for Experimental Neurotherapeutics (ASENT) 2024 Annual Meeting
Avenue Therapeutics, Inc. today announced that Amy Chappell, M.D., FAAN will be presenting preclinical in vivo data evaluating BAER-101 using the SynapCell’s Genetic Absence Epilepsy Rat from Strasbourg (“GAERS”) model of epilepsy at the American Society for Experimental Neurotherapeutics (ASENT) 2024 Annual Meeting on Wednesday, March 13, 2024.
March 11, 2024
·
6 min read
Press Releases
TreeFrog Publishes Results of First Successful Bioproduction of a Parkinson’s Disease Cell Therapy in Scalable Bioreactor in Neurotherapeutics Journal
October 1, 2024
·
5 min read
Drug Development
Embera NeuroTherapeutics Announces First Subject Dosed in Phase 2 Study of EMB-001 in Cocaine Use Disorder
Embera NeuroTherapeutics, Inc., a specialty pharmaceutical company developing novel treatments for cocaine, nicotine and potentially other addictions, today announced that the first subjects have begun dosing of EMB-001 in a Phase 2 study for cocaine use disorder.
August 31, 2020
·
4 min read
Genetown
Cerevance to Participate in Precision Neurotherapeutics Panel During the 2024 BIO International Convention
Cerevance announced that Craig Thompson, chief executive officer, will participate in a panel at the 2024 BIO International Convention, taking place in San Diego, CA from June 3 – 6, 2024.
May 20, 2024
·
2 min read
Drug Development
Viage Therapeutics announces data from a Phase 1 study with DGX-001, a first-in-class oral neurotherapeutic targeting cognitive impairment in patients with Alzheimer’s Disease and Parkinson’s Disease
Viage Therapeutics (Viage), a neuroscience company based on a platform of novel neurotherapeutics, today announced positive findings from its Phase 1 study of DGX-001, a first-in class oral therapeutic targeting the AVPR1A receptor in the gut.
July 26, 2023
·
3 min read
Press Releases
Nika Pharmaceuticals, Inc. (NIKA) Latest Developments
April 14, 2025
·
2 min read
Press Releases
Penumbra, Inc. Reports First Quarter 2025 Financial Results
April 23, 2025
·
15 min read
1 of 69,815
Next
